Delivery Order SPE2DB25D7056-SPE2DB25FTNAL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,768.84 to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops (5ml) on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $2,121.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml), with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,896.43 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes firm fixed price pricing with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,987.06 delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,653 to Amerisourcebergen Drug Corporation for the supply of Lumigan 0.01% eye drops. To be performed in Conshohocken, Pennsylvania from July 28 through July 31, 2023, this order is issued against an existing DLA pharmaceuticals contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested ophthalmic solution...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of LUMIGAN 0.01% eye drops. The $4,409.48 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,361.88 firm fixed-price contract is for the delivery of LUMIGAN 0.01% eye drops, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LUMIGAN 0.01% eye drops in 5 ml containers. The contract is a firm fixed-price delivery order, with a ceiling value of $2,640.89 and a period of performance through May 13, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 to provide a...
- The Defense Logistics Agency awarded a $10,175.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for LUMIGAN 0.01% eye drops. As the prime contractor, Amerisourcebergen will supply five milliliters of the ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility by August 25, 2023 under the parent company Amerisourcebergen Corporation. No subcontractors or set aside designations were identified. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, with a ceiling value of $3,635.40. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of April 10, 2025. This contract award is not associated with a set-aside designation, indicating...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTNALDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops in 5mL quantities under a firm fixed price contract. The award, issued on August 19, 2025, carries a ceiling value of $2,108.68 with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. Through its comprehensive global pharmaceutical support vehicle with DLA, the company supplies a diverse range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for ophthalmic medication aligns with AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts, which consistently demonstrate the company's capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/19/25 |